Rakovina Therapeutics Inc.

About Rakovina Therapeutics Inc.

Rakovina Therapeutics is dedicated to advancing drug discovery and research using cutting-edge technology, particularly AI, to develop new cancer treatments and improve patient lives worldwide.

Products & Services

kt-2000AI:A drug development program focused on cancer treatment, leveraging AI technology.

kt-3000 series:A series of drugs under development targeting various cancer types.

Specialties

AI-powered drug discovery Cancer treatment research Targeted therapies for breast, ovarian, prostate, and pancreatic cancer

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 1454000 MR: - FA: $1,454,000.00 FAN: 1454000	D: 2025-11-28 FD: 2025-11-28	-

Debt Latest

2025-11-28

$1.5M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mads Daugaard

President & Chief Scientific Officer

D

David Kideckel

Chief Financial Officer

A

Artem Cherkasov

Senior AI & Medicinal Chemistry Advisor

J

John Langlands

Chief Operating Officer

M

Michelle Seltenrich

Director, Corporate Development

J

Jeffrey Bacha

Executive Chairman

View 10 more team members with Pro

Unlock Full Team Directory

Recent News